A 20-year experience on malignant lymphomas in patients aged 70 and older at a single institute

被引：10

作者：

Tirelli, U

Carbone, A

Monfardini, S

Zagonel, V

机构：

[1] Natl Canc Inst, Div Med Oncol A, I-33081 Aviano, PN, Italy

[2] Natl Canc Ctr, Div Pathol, Aviano, Italy

[3] Gen Hosp, Div Med Oncol, Padua, Italy

[4] Natl Canc Ctr, Div Med Oncol, Aviano, Italy

来源：

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | 2001年 / 37卷 / 02期

关键词：

elderly patients; non-Hodgkin's lymphoma; Hodgkin's disease;

D O I：

10.1016/S1040-8428(00)00103-7

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

We have evaluated the clinico-pathological and therepeutical outcome of patients aged 70 and older with malignant lymphomas treated at a single institute over a 20-year period of time. Among the several studies evaluated, the most important is a prospective randomized study comparing a new regimen, VMP (VP 16, Mitoxantrone and Prednimustine) vs the goal standard CHOP in unfavorable non-Hodgkin's lymphoma (NHL), showing that CHOP is significantly better than VMP in terms of objective response rate, progression free and overall survival. Therefore CHOP remains the standard regimen also for patients of over 70 years of age and stage II-IV intermediate and high grade NHL. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.

引用

页码：153 / 158

页数：6

共 11 条

[1]

ANDERSON JR, 1995, ANN ONCOL, V6, P167

[2]

CALIFARETTI N, 1998, P ASCO LOS ANG

[3]

CARBONE A, 1990, CANCER, V66, P1991, DOI 10.1002/1097-0142(19901101)66:9<1991::AID-CNCR2820660924>3.0.CO

[4]

2-4

[5]

MONFARDINI S, 1996, ANN ONCOL, V7, P164

[6] A PROSPECTIVE-STUDY OF A NEW COMBINATION CHEMOTHERAPY REGIMEN IN PATIENTS OLDER THAN 70 YEARS WITH UNFAVORABLE NON-HODGKINS-LYMPHOMA [J].

TIRELLI, U ;

ZAGONEL, V ;

ERRANTE, D ;

SERRAINO, D ;

TALAMINI, R ;

DECICCO, M ;

CARBONE, A ;

MONFARDINI, S .

JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (02) :228-236

[7] NON-HODGKINS LYMPHOMAS IN 137 PATIENTS AGED 70 YEARS OR OLDER - A RETROSPECTIVE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER LYMPHOMA GROUP-STUDY [J].

TIRELLI, U ;

ZAGONEL, V ;

SERRAINO, D ;

THOMAS, J ;

HOERNI, B ;

TANGURY, A ;

RUHL, U ;

BEY, P ;

TUBIANA, N ;

BREED, WPM ;

ROOZENDAAL, KJ ;

HAGENBEEK, A ;

HUPPERETS, PS ;

SOMERS, R .

JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (11) :1708-1713

[8] CHOP is the standard regimen in patients ≥70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma:: Results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group [J].

Tirelli, U ;

Errante, D ;

Van Glabbeke, M ;

Teodorovic, I ;

Kluin-Nelemans, JC ;

Thomas, J ;

Bron, D ;

Rosti, G ;

Somers, R ;

Zagonel, V ;

Noordijk, EM .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) :27-34

[9] HODGKINS-DISEASE IN PATIENTS 70 YEARS OF AGE OR MORE - A RETROSPECTIVE EORTC LYMPHOMA GROUP-STUDY [J].

TIRELLI, U ;

SERRAINO, D ;

ZAGONEL, V ;

EGHBALI, H ;

DIEHL, V .

CANCER INVESTIGATION, 1990, 8 (06) :643-644

[10] NON-HODGKINS-LYMPHOMAS IN THE ELDERLY - PROSPECTIVE STUDIES WITH SPECIFICALLY DEVISED CHEMOTHERAPY REGIMENS IN 66 PATIENTS [J].

TIRELLI, U ;

CARBONE, A ;

ZAGONEL, V ;

VERONESI, A ;

CANETTA, R .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (05) :535-540

← 1 2 →